(Bloomberg) -- Malaysia is set to widen its vaccine roll-out to those as young as five years old after it granted conditional registration for Pfizer-BioNTech's Cominarty 10mcg vaccine.
- The national Drug Control Authority also issued conditional registration to CanSino Biologics' vaccine as a booster shot for adults over the age of 18, said Health Director-General Noor Hisham Abdullah in a statement Thursday
- NOTE: This is in addition to the Pfizer, AstraZeneca and Sinovac vaccines already approved for booster doses
- The conditional registration requires continuous monitoring and evaluation of the quality, safety and efficacy of the vaccines
- Malaysia will avoid reimposing a lockdown as much as possible despite the spread of the omicron variant, said Health Minister Khairy Jamaluddin in a briefing Thursday
- The majority of the cases stem from pilgrims returning from Saudi Arabia; 14% of them were unvaccinated and in violation of government rules
- Malaysia is suspending for one month all religious pilgrimage to Saudi Arabia effective Saturday, and reviewing its virus protocols on the matter
- Malaysia has a total 245 omicron cases, 12 of which are local transmissions
©2022 Bloomberg L.P.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
- The majority of the cases stem from pilgrims returning from Saudi Arabia; 14% of them were unvaccinated and in violation of government rules
